FAF1 Gene Involvement in Pituitary Corticotroph Tumors.
Journal
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
ISSN: 1439-4286
Titre abrégé: Horm Metab Res
Pays: Germany
ID NLM: 0177722
Informations de publication
Date de publication:
08 Dec 2023
08 Dec 2023
Historique:
medline:
9
12
2023
pubmed:
9
12
2023
entrez:
8
12
2023
Statut:
aheadofprint
Résumé
Cushing's disease (CD) is caused by rare pituitary corticotroph tumors that lead to corticotropin (ACTH) excess. Variants in
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Thieme. All rights reserved.
Déclaration de conflit d'intérêts
CAS, FRF, and GT hold a patent on GPR101 and its function (US Patent No. 10,350,273, Treatment of Hormonal Disorders of Growth). CAS also holds patents on the function of the PRKAR1A and PDE11A genes and related issues; his laboratory had received research funding on the GPR101 gene, and on abnormal growth hormone secretion and its treatment by Pfizer, Inc. CAS is currently employed by ELPEN, SA and has been consulting for Lundbeck Pharmaceuticals and Sync, SA. CT received research funding on treatment of abnormal growth hormone secretion by Pfizer, Inc.